SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-20-141025
Filing Date
2020-12-31
Accepted
2020-12-31 17:00:11
Documents
4
Period of Report
2020-12-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2039640d1_8ka.htm 8-K/A 28746
2 EXHIBIT 10.1 tm2039640d1_ex10-1.htm EX-10.1 31480
3 EXHIBIT 99.1 tm2039640d1_ex99-1.htm EX-99.1 716274
4 EXHIBIT 99.2 tm2039640d1_ex99-2.htm EX-99.2 531141
  Complete submission text file 0001104659-20-141025.txt   1308899
Mailing Address 5301 WISCONSIN AVENUE NW SUITE 570 WASHINGTON DC 20015
Business Address 5301 WISCONSIN AVENUE NW SUITE 570 WASHINGTON DC 20015 301-215-7440
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39752 | Film No.: 201429342
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences